🇺🇸 FDA
Patent

US 10098945

Genetically engineered swine influenza virus and uses thereof

granted A61KA61K2039/5254A61K2039/5256

Quick answer

US patent 10098945 (Genetically engineered swine influenza virus and uses thereof) held by The United States of America, as represented by the Secretary of Agriculture expires Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary of Agriculture
Grant date
Tue Oct 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
34
CPC classes
A61K, A61K2039/5254, A61K2039/5256, A61K2039/544, A61K2039/552